BACITRACIN ZINC AND POLYMYXIN B SULFATE

Post-LOE

bacitracin zinc; polymyxin b sulfate

Design Pharmaceuticals

ANDAOPHTHALMICOINTMENT

Approved

Feb 2002

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

2/8 — Basic

BACITRACIN ZINC AND POLYMYXIN B SULFATE (bacitracin zinc; polymyxin b sulfate) by Design Pharmaceuticals. Approved for infection in minor cuts scrapes burns. First approved in 2002.

Drug data last refreshed 1w ago

Mechanism of Action

Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.

Indications (1)

infection in minor cuts scrapes burns

Company

Worked on BACITRACIN ZINC AND POLYMYXIN B SULFATE at Design Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.